Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
39
EUDA Quote, Financials, Valuation and Earnings
Last price:
$4.59
Seasonality move
:
6.64%
Day range:
$4.43 - $4.70
52-week range:
$1.20 - $6.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
66.85x
P/B ratio:
--
Volume:
109.5K
Avg. volume:
104.6K
1-year change:
216.33%
Market cap:
$172.8M
Revenue:
$3.7M
EPS (TTM):
-$0.64
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, EUDA Health Holdings has 29.03% upside to fair value with a price target of -- per share.
EUDA vs. S&P 500
-
Over the past 5 trading days, EUDA Health Holdings has overperformed the S&P 500 by 0.15% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
EUDA Health Holdings does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
EUDA Health Holdings has grown year-over-year revenues for 0 quarters straight. In the most recent quarter EUDA Health Holdings reported revenues of --.
Earnings Growth
-
EUDA Health Holdings has grown year-over-year earnings for 0 quarters straight. In the most recent quarter EUDA Health Holdings reported earnings per share of --.
Enterprise value:
174.9M
EV / Invested capital:
--
Price / LTM sales:
66.85x
EV / EBIT:
29.39x
EV / Revenue:
133.65x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-134.58x
Price / Operating cash flow:
39.19x
Enterprise value / EBITDA:
25.77x
Gross Profit (TTM):
-$444.2K
Return On Assets:
-344.5%
Net Income Margin (TTM):
-1319.98%
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2022-06-30 | 2023-06-30 | |
| Income Statement | ||||||
| Revenue | -- | $10.5M | $7.9M | $2.4M | $104.3K | |
| Gross Profit | -- | -- | -- | $660.6K | $40.1K | |
| Operating Income | -- | -- | -- | -$1.7M | -$739K | |
| EBITDA | -- | -- | -- | -$1.7M | -$4.8M | |
| Diluted EPS | -- | -- | -- | -$0.20 | -$0.28 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $4.2M | $1.5M | $1.1M | |
| Total Assets | -- | -- | $7.1M | $2.1M | $2M | |
| Current Liabilities | -- | -- | $8M | $7.9M | $7.9M | |
| Total Liabilities | -- | -- | $8.1M | $8.1M | $8M | |
| Total Equity | -- | -- | -$1M | -$6M | -$6M | |
| Total Debt | -- | -- | -- | -- | $2.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2022-06-30 | 2023-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$1.3M | -- | -$976.7K | -$1.7M | |
| Cash From Investing | -- | -- | -- | -$124.1K | -$1.1K | |
| Cash From Financing | -- | -- | -- | $1M | $1.2M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
EUDA
Sector
Market Cap
$172.8M
$48.9M
Price % of 52-Week High
73.81%
49.34%
Dividend Yield
0%
0%
Shareholder Yield
-0.74%
-0.74%
1-Year Price Total Return
216.33%
-30.56%
Beta (5-Year)
--
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$4.48
200-day SMA
Buy
Level
$3.51
Bollinger Bands (100)
Buy
Level
3.77 - 4.85
Chaikin Money Flow
Sell
Level
-22M
20-day SMA
Sell
Level
$4.89
Relative Strength Index (RSI14)
Sell
Level
49.97
ADX Line
Sell
Level
16.38
Williams %R
Neutral
Level
-69.3396
50-day SMA
Buy
Level
$4.56
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
63.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-60.3853)
Sell
CA Score
(Annual)
Level (-7.3464)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (54.7184)
Buy
Piotroski F Score
(Annual)
Level (4)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company’s proprietary unified AI platform quickly assesses a patient’s medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.
Stock Forecast FAQ
In the current month, EUDA has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EUDA average analyst price target in the past 3 months is --.
-
Where Will EUDA Health Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that EUDA Health Holdings share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About EUDA Health Holdings?
Analysts are divided on their view about EUDA Health Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that EUDA Health Holdings is a Sell and believe this share price will drop from its current level to --.
-
What Is EUDA Health Holdings's Price Target?
The price target for EUDA Health Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is EUDA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for EUDA Health Holdings is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of EUDA?
You can purchase shares of EUDA Health Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase EUDA Health Holdings shares.
-
What Is The EUDA Health Holdings Share Price Today?
EUDA Health Holdings was last trading at $4.59 per share. This represents the most recent stock quote for EUDA Health Holdings. Yesterday, EUDA Health Holdings closed at $4.65 per share.
-
How To Buy EUDA Health Holdings Stock Online?
In order to purchase EUDA Health Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
